IonQ advances in DARPA program and expands platform sales

what happened

According to TradingView, IonQ, Inc. (NYSE: IONQ) advanced to Stage C of DARPA’s quantum benchmarking program and signed an agreement running through 2029. The deal covers independent verification and testing of multiple generations of the company’s Superion memory and interconnect systems. The development was among the key events highlighted in the weekly recap.

IonQ also reported commercial sales of its memory and interconnect platform. The first sale went to the University of Maryland in April 2026, followed by a second sale to SDT in South Korea in September 2026. DARPA’s HARQ program is using IonQ’s architecture to develop high-speed quantum links that can work with multiple qubit types.

Bank of America initiated coverage of IonQ with a Buy rating and a $60 target, citing the company’s leading revenue position and semiconductor-based approach, which it said could support scaling and engineering gains by 2030. The shares rose about 2% premarket after the DARPA milestone, but remained down about 10% year to date in 2026 as investors pointed to losses and slow growth. ETFs with large IONQ holdings may also affect share flows. TradingView said the summary was AI-generated and could contain inaccuracies, urging verification of important information against original sources.

why it matters

The update combines government validation, initial commercial platform sales and new analyst coverage. At the same time, the year-to-date decline and concerns about losses and growth indicate that investors continue to weigh execution and financial performance alongside the company’s technical milestones.

instruments